SRRK.US Scholar Rock Holding Corp

Healthcare Biotechnology USA Stocks
45.08 USD
Close of Nov 17, 2026
37.54 61.76
Market cap
USD 5.50B
P/E
-
P/B
32.21x
ROE
-255.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is SRRK.US undervalued?

Graham number

The Graham number of Scholar Rock Holding Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Scholar Rock Holding Corp fundamental analysis

No fundamental analysis for Scholar Rock Holding Corp yet.

Scholar Rock Holding Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Scholar Rock Holding Corp

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on improving the lives of children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. The company's novel understanding of the molecular mechanisms of growth factor activation within the transforming growth factor beta (TGFß) superfamily has enabled the development of a proprietary platform. This platform is used for the development of monoclonal…

Full company profile